BACKGROUND: The recurrence rate of sinonasal inverted papillomas (SNIP) is 15-20%. However, few studies have investigated patient-dependent factors related to recurrence of SNIPs. OBJECTIVE: To analyze risk factors, including human papilloma virus (HPV) infection and smoking, as well as other factors, for recurrence of SNIPs. METHODS: Fifty-four patients who were diagnosed with SNIP and underwent surgery were enrolled: 39 men and 15 women, with the mean age of 54.0 years. Their mean follow-up was 40.6 months. Demographics and information about the history of smoking, previous surgery, tumor extent, follow-up, and recurrence were reviewed retrospectively. Those patients whose tumors were associated with malignant transformation were excluded in this study. HPV detection and genotyping in the tumor specimens were performed with the HPV DNA chip, a polymerase chain reaction-based DNA microarray system. RESULTS: Seven patients (13.0%) had recurrence, with a mean time to recurrence of 39.8 months. Recurrence rates in T1, T2, T3, and T4 of the Krouse staging system were 0% (0/4), 8.3% (2/24), 17.4% (4/23), and 33.3% (1/3), respectively (p > 0.5). Eight patients (14.8%) were positive for HPV DNA. All of these patients belonged to the group without recurrence (p > 0.5). However, recurrence rates according to HPV DNA positivity were not statistically different (0% versus 15.2%). Three (42.9%) in the group with recurrence and four (8.5%) in the group without recurrence were smokers (p < 0.5). CONCLUSION: Smoking was associated with recurrence of SNIP. However, HPV infection is not a recurrence of SNIP risk factor.
BACKGROUND: The recurrence rate of sinonasal inverted papillomas (SNIP) is 15-20%. However, few studies have investigated patient-dependent factors related to recurrence of SNIPs. OBJECTIVE: To analyze risk factors, including human papilloma virus (HPV) infection and smoking, as well as other factors, for recurrence of SNIPs. METHODS: Fifty-four patients who were diagnosed with SNIP and underwent surgery were enrolled: 39 men and 15 women, with the mean age of 54.0 years. Their mean follow-up was 40.6 months. Demographics and information about the history of smoking, previous surgery, tumor extent, follow-up, and recurrence were reviewed retrospectively. Those patients whose tumors were associated with malignant transformation were excluded in this study. HPV detection and genotyping in the tumor specimens were performed with the HPV DNA chip, a polymerase chain reaction-based DNA microarray system. RESULTS: Seven patients (13.0%) had recurrence, with a mean time to recurrence of 39.8 months. Recurrence rates in T1, T2, T3, and T4 of the Krouse staging system were 0% (0/4), 8.3% (2/24), 17.4% (4/23), and 33.3% (1/3), respectively (p > 0.5). Eight patients (14.8%) were positive for HPV DNA. All of these patients belonged to the group without recurrence (p > 0.5). However, recurrence rates according to HPV DNA positivity were not statistically different (0% versus 15.2%). Three (42.9%) in the group with recurrence and four (8.5%) in the group without recurrence were smokers (p < 0.5). CONCLUSION: Smoking was associated with recurrence of SNIP. However, HPV infection is not a recurrence of SNIP risk factor.
Authors: Franklin Mariño-Sánchez; Gonzalo de Los Santos; Ana Giribet; Alejandra Aguirre; Javier Alonso; Daniel L Wansley; Ignacio Cobeta Journal: Indian J Otolaryngol Head Neck Surg Date: 2018-03-16
Authors: Jake J Lee; Lauren T Roland; Jordan J Licata; Hilary L P Orlowski; Pawina Jiramongkolchai; Jay F Piccirillo; Dorina Kallogjeri; Cristine N Klatt-Cromwell; Rebecca D Chernock; John S Schneider Journal: Laryngoscope Date: 2019-05-21 Impact factor: 3.325
Authors: A Pähler Vor der Holte; I Fangk; S Glombitza; L Wilkens; H J Welkoborsky Journal: Eur Arch Otorhinolaryngol Date: 2019-12-12 Impact factor: 2.503
Authors: M Fulla; T Szafarowski; J Frias-Gomez; B Quiros; O Clavero; M Gomà; M A Pavon; O Jurek-Matusiak; H R Lares; M Mañós; L Alemany; M Mena; X Gonzalez Journal: Head Neck Pathol Date: 2020-01-08
Authors: Marta Gamrot-Wrzoł; Paweł Sowa; Grażyna Lisowska; Wojciech Ścierski; Maciej Misiołek Journal: Biomed Res Int Date: 2017-11-09 Impact factor: 3.411
Authors: Anja Paehler Vor der Holte; Inger Fangk; Sabine Glombitza; Ludwig Wilkens; Hans J Welkoborsky Journal: Cancer Med Date: 2020-12-22 Impact factor: 4.452